Lifecore Biomedical, Inc. \De\ (LFCR) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $6.44, +0.31% vs the prior close of $6.42.
- Volume 233.40K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LFCR rises 0.3% to $6.44. Closed at $6.44, +0.31% vs the prior close of $6.42. Day range $6.42–$6.48, opened at $6.44.
LFCR daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — LFCR rises 0.3% to $6.44
- Closed at $6.44, +0.31% vs the prior close of $6.42. Day range $6.42–$6.48, opened at $6.44.
- Volume was 233.40K shares, 0.7x its 50-day average of 357.73K.
- Price is +27.8% vs its 50-day average ($5.04) and +15.3% vs its 200-day average ($5.59).
- 52-week range $3.63–$8.98; today's close sits at 53% of that range, 28.3% below the 52-week high.
Oct 14, 2026 — LFCR ends flat (+0.0%) to $6.42, 3 down days in a row
- Closed at $6.42, +0.00% vs the prior close of $6.42. Day range $6.40–$6.44, opened at $6.40.
- Volume was 268.00K shares, 0.8x its 50-day average of 354.93K.
- Price is +28.4% vs its 50-day average ($5.00) and +14.7% vs its 200-day average ($5.60).
- 52-week range $3.63–$8.98; today's close sits at 52% of that range, 28.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — LFCR dips 0.3% to $6.42
- Closed at $6.42, -0.31% vs the prior close of $6.44. Day range $6.40–$6.46, opened at $6.46.
- Volume was 590.60K shares, 1.7x its 50-day average of 345.74K.
- Price is +29.5% vs its 50-day average ($4.96) and +14.5% vs its 200-day average ($5.61).
- 52-week range $3.63–$8.98; today's close sits at 52% of that range, 28.5% below the 52-week high.
Oct 12, 2026 — LFCR ends flat (-0.2%) to $6.44
- Closed at $6.44, -0.16% vs the prior close of $6.45. Day range $6.43–$6.46, opened at $6.45.
- Volume was 312.00K shares, 0.9x its 50-day average of 341.07K.
- Price is +31.0% vs its 50-day average ($4.92) and +14.7% vs its 200-day average ($5.62).
- 52-week range $3.63–$8.98; today's close sits at 53% of that range, 28.3% below the 52-week high.
Oct 9, 2026 — LFCR rises 0.3% to $6.45
- Closed at $6.45, +0.31% vs the prior close of $6.43. Day range $6.42–$6.46, opened at $6.43.
- Volume was 387.10K shares, 1.1x its 50-day average of 338.03K.
- Price is +32.2% vs its 50-day average ($4.88) and +14.7% vs its 200-day average ($5.62).
- 52-week range $3.63–$8.98; today's close sits at 53% of that range, 28.2% below the 52-week high.
Oct 8, 2026 — LFCR ends flat (-0.2%) to $6.43, 4 down days in a row
- Closed at $6.43, -0.16% vs the prior close of $6.44. Day range $6.42–$6.46, opened at $6.43.
- Volume was 492.10K shares, 1.5x its 50-day average of 332.42K.
- Price is +33.0% vs its 50-day average ($4.84) and +14.2% vs its 200-day average ($5.63).
- 52-week range $3.63–$8.98; today's close sits at 52% of that range, 28.4% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — LFCR ends flat (-0.2%) to $6.44 on 5.7x normal volume
- Closed at $6.44, -0.16% vs the prior close of $6.45. Day range $6.43–$6.48, opened at $6.45.
- Volume was 1.72M shares, 5.7x its 50-day average of 300.80K — unusually heavy trading.
- Price is +34.4% vs its 50-day average ($4.79) and +14.2% vs its 200-day average ($5.64).
- 52-week range $3.63–$8.98; today's close sits at 53% of that range, 28.3% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — LFCR dips 1.1% to $6.45 on 4.4x normal volume
- Closed at $6.45, -1.07% vs the prior close of $6.52. Day range $6.44–$6.54, opened at $6.51.
- Volume was 1.23M shares, 4.4x its 50-day average of 278.39K — unusually heavy trading.
- Price is +35.7% vs its 50-day average ($4.75) and +14.2% vs its 200-day average ($5.65).
- 52-week range $3.63–$8.98; today's close sits at 53% of that range, 28.2% below the 52-week high.
Oct 5, 2026 — LFCR dips 0.3% to $6.52 on 3.2x normal volume
- Closed at $6.52, -0.31% vs the prior close of $6.54. Day range $6.51–$6.57, opened at $6.54.
- Volume was 840.60K shares, 3.2x its 50-day average of 263.71K — unusually heavy trading.
- Price is +38.4% vs its 50-day average ($4.71) and +15.2% vs its 200-day average ($5.66).
- 52-week range $3.63–$8.98; today's close sits at 54% of that range, 27.4% below the 52-week high.
Oct 2, 2026 — LFCR ends flat (+0.2%) to $6.54 on 2.0x normal volume
- Closed at $6.54, +0.15% vs the prior close of $6.53. Day range $6.53–$6.55, opened at $6.55.
- Volume was 504.50K shares, 2.0x its 50-day average of 256.07K — unusually heavy trading.
- Price is +40.2% vs its 50-day average ($4.67) and +15.4% vs its 200-day average ($5.67).
- 52-week range $3.63–$8.98; today's close sits at 54% of that range, 27.2% below the 52-week high.
LFCR latest news & SEC filings
Every SEC filing by or about LFCR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 28, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 28, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$6.16M
- Diluted EPS: -$0.19
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 2, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 2, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade LFCR
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 16, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.39% (largest 55.2%). That is a volatile stock.
- Liquidity: about 693.16K shares (≈$4.46M) trade per day on average.
- 52-week position: $6.44 vs a range of $3.63–$8.98 (53% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 29, 2026; 8-K Sep 28, 2026; 10-Q Aug 5, 2026.
- Share count: 37.85M shares outstanding (Jul 29, 2026), +1.2% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
LFCR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 6.44 | 6.48 | 6.42 | 6.44 | 233.40K |
| Oct 14, 2026 | 6.40 | 6.44 | 6.40 | 6.42 | 268.00K |
| Oct 13, 2026 | 6.46 | 6.46 | 6.40 | 6.42 | 590.60K |
| Oct 12, 2026 | 6.45 | 6.46 | 6.43 | 6.44 | 312.00K |
| Oct 9, 2026 | 6.43 | 6.46 | 6.42 | 6.45 | 387.10K |
| Oct 8, 2026 | 6.43 | 6.46 | 6.42 | 6.43 | 492.10K |
| Oct 7, 2026 | 6.45 | 6.48 | 6.43 | 6.44 | 1.72M |
| Oct 6, 2026 | 6.51 | 6.54 | 6.44 | 6.45 | 1.23M |
| Oct 5, 2026 | 6.54 | 6.57 | 6.51 | 6.52 | 840.60K |
| Oct 2, 2026 | 6.55 | 6.55 | 6.53 | 6.54 | 504.50K |
| Oct 1, 2026 | 6.57 | 6.58 | 6.53 | 6.53 | 707.00K |
| Sep 30, 2026 | 6.55 | 6.61 | 6.54 | 6.58 | 970.20K |
| Sep 29, 2026 | 6.53 | 6.61 | 6.51 | 6.59 | 685.30K |
| Sep 28, 2026 | 6.52 | 6.65 | 6.40 | 6.52 | 4.01M |
| Sep 25, 2026 | 4.27 | 4.39 | 4.12 | 4.20 | 70.50K |
| Sep 24, 2026 | 4.41 | 4.41 | 4.21 | 4.29 | 97.20K |
| Sep 23, 2026 | 4.45 | 4.49 | 4.39 | 4.40 | 205.20K |
| Sep 22, 2026 | 4.52 | 4.52 | 4.37 | 4.50 | 90.40K |
| Sep 21, 2026 | 4.48 | 4.51 | 4.22 | 4.48 | 170.70K |
| Sep 18, 2026 | 4.44 | 4.55 | 4.33 | 4.46 | 280.80K |
About Lifecore Biomedical, Inc. \De\
Lifecore Biomedical, Inc. \De\ (LFCR) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CHASKA, MN. State of incorporation: DE. Fiscal year ends May 25. SEC CIK 1005286.
LFCR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Humberto Calheiros Antunes | Director | Jun 5, 2026 |
| Jason Aryeh | Director | Jun 5, 2026 |
| Lovas Katrina Houde | Director | Jun 5, 2026 |
| Paul Harold Johnson | Director | Jun 5, 2026 |
| Paul Josephs | Chief Executive Officer | May 21, 2026 |
| Christopher S Kiper | Director | Jun 8, 2026 |
| Matthew E Korenberg | Director | Jun 5, 2026 |
| Partners Asset Management, Llc Legion | Director | Jun 8, 2026 |
| Partners Holdings, Llc Legion | Director | Jun 8, 2026 |
| Partners, L.P. I Legion | Director | Jun 8, 2026 |
| Partners, L.P. Ii Legion | Director | Jun 8, 2026 |
| Partners, Llc Legion | Director | Jun 8, 2026 |
| Nelson Obus | Director | Jun 5, 2026 |
| Joshua Schechter | Director | Jun 5, 2026 |
| Raymond T. White | Director | Jun 8, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Paul Josephs | Chief Executive Officer | May 21, 2026 |
| Thomas D. Salus | Chief Legal & Administration | Apr 16, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
LFCR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| May 25, 2025 | — | $-38.72M | -1.27 | $-206.00K |
| May 26, 2024 | — | $12.01M | 0.33 | $257.00K |
| May 28, 2023 | — | $-99.56M | -3.32 | $-17.44M |
| May 29, 2022 | — | $-116.72M | -3.97 | $-22.59M |
| May 30, 2021 | — | $-32.29M | -1.10 | $16.47M |
Latest balance sheet: total assets $229.50M, total liabilities $213.41M, cash $17.24M (as of Jun 30, 2026).
LFCR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $4.44 |
| May 6, 2026 | 8-K Item 2.02 (results) | $4.96 |
| Mar 16, 2026 | 8-K Item 2.02 (results) | $4.37 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $6.62 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $7.76 |
| Apr 3, 2025 | 8-K Item 2.02 (results) | $6.81 |
| Jan 2, 2025 | 8-K Item 2.02 (results) | $6.66 |
| Oct 4, 2024 | 8-K Item 2.02 (results) | — |
| Aug 26, 2024 | 8-K Item 2.02 (results) | — |
| Apr 1, 2024 | 8-K Item 2.02 (results) | — |
| Mar 20, 2024 | 8-K Item 2.02 (results) | — |
| Aug 31, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on LFCR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.